Literature DB >> 10092085

SF2 and SRp55 regulation of CD45 exon 4 skipping during T cell activation.

R Lemaire1, A Winne, M Sarkissian, R Lafyatis.   

Abstract

CD45 is an alternatively spliced membrane phosphatase required for T cell activation. Exons 4, 5 and 6 can be included or skipped from spliced mRNA resulting in several protein isoforms that include or exclude epitopes referred to as RA, RB or RC, respectively. T cells reciprocally express CD45RA or CD45RO (lacking all three exons), corresponding to naive versus memory T cells. Overexpression of the alternative splicing regulators, SF2 or SWAP, induces skipping of CD45 exon 4 in transfected COS cells. We show here that the arginine/serine-rich domain of SWAP and the RNA recognition motifs of SF2 are required for skipping of CD45 exon 4. Unlike SWAP, SF2 specifically regulated alternative splicing of CD45 exon 4, having no effect on a non-regulated exon of CD45 (exon 9). Like SF2 and SWAP, the SR proteins SC35, SRp40 and SRp75, but not SRp55 also induced CD45 exon 4 skipping. In contrast, antisense inhibition of SRp55 induced exon 4 skipping. SF2 and SRp55 proteins were not detectable or expressed at a very low level in freshly isolated CD45RA+ and CD45RO+ T cells. Activation of CD45RA+ T cells shifted CD45 expression from CD45RA to CD45RO, and induced a large increase in expression of both SF2 and SRp55. Thus, SF2 at least in part determines splicing of CD45 exon 4 during T cell activation. SRp55, SR protein phosphorylation, or other splicing factors likely regulate CD45 splicing in CD45RO+ memory T cells. The different SR proteins expressed by memory and activated T cells emphasize the different phenotypes of these cell types that both express CD45RO.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092085     DOI: 10.1002/(SICI)1521-4141(199903)29:03<823::AID-IMMU823>3.0.CO;2-C

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras.

Authors:  K W Lynch; A Weiss
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  FF domains of CA150 bind transcription and splicing factors through multiple weak interactions.

Authors:  Matthew J Smith; Sarang Kulkarni; Tony Pawson
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

3.  Characterization of mammalian Par 6 as a dual-location protein.

Authors:  Erin G Cline; W James Nelson
Journal:  Mol Cell Biol       Date:  2007-04-09       Impact factor: 4.272

4.  SRSF1 RNA Recognition Motifs Are Strong Inhibitors of HIV-1 Replication.

Authors:  Sean Paz; Michael L Lu; Hiroshi Takata; Lydie Trautmann; Massimo Caputi
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

5.  Significant linkage to chromosome 12q24.32-q24.33 and identification of SFRS8 as a possible asthma susceptibility gene.

Authors:  C Brasch-Andersen; Q Tan; A D Børglum; A Haagerup; T R Larsen; J Vestbo; T A Kruse
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

6.  Regulation of alternative splicing within the supraspliceosome.

Authors:  Naama Sebbag-Sznajder; Oleg Raitskin; Minna Angenitzki; Taka-Aki Sato; Joseph Sperling; Ruth Sperling
Journal:  J Struct Biol       Date:  2011-11-12       Impact factor: 2.867

Review 7.  Regulation of splicing by SR proteins and SR protein-specific kinases.

Authors:  Zhihong Zhou; Xiang-Dong Fu
Journal:  Chromosoma       Date:  2013-03-24       Impact factor: 4.316

8.  Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.

Authors:  Vaishali R Moulton; Alexandros P Grammatikos; Lisa M Fitzgerald; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

9.  Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2.

Authors:  Erin M Bennett; Andrew M L Lever; Jane F Allen
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Protein kinase C-dependent control of Bcl-x alternative splicing.

Authors:  Timothée Revil; Johanne Toutant; Lulzim Shkreta; Daniel Garneau; Philippe Cloutier; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2007-10-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.